NO944247L - Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor - Google Patents

Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor

Info

Publication number
NO944247L
NO944247L NO944247A NO944247A NO944247L NO 944247 L NO944247 L NO 944247L NO 944247 A NO944247 A NO 944247A NO 944247 A NO944247 A NO 944247A NO 944247 L NO944247 L NO 944247L
Authority
NO
Norway
Prior art keywords
receptor
vitamin
transcobalamin
blocking agents
growth blocking
Prior art date
Application number
NO944247A
Other languages
English (en)
Other versions
NO944247D0 (no
Inventor
Jr Alton Charles Morgan
Original Assignee
Receptagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Receptagen Corp filed Critical Receptagen Corp
Publication of NO944247D0 publication Critical patent/NO944247D0/no
Publication of NO944247L publication Critical patent/NO944247L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO944247A 1992-05-08 1994-11-07 Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor NO944247L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88054092A 1992-05-08 1992-05-08
PCT/US1993/004341 WO1993023557A1 (en) 1992-05-08 1993-05-07 Anti-receptor agents to the vitamin b12/transcobalamin ii receptor

Publications (2)

Publication Number Publication Date
NO944247D0 NO944247D0 (no) 1994-11-07
NO944247L true NO944247L (no) 1995-01-09

Family

ID=25376514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944247A NO944247L (no) 1992-05-08 1994-11-07 Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor

Country Status (11)

Country Link
US (1) US5688504A (no)
EP (1) EP0644948B1 (no)
JP (1) JPH07508174A (no)
KR (1) KR950701390A (no)
AT (1) ATE163679T1 (no)
AU (1) AU680822B2 (no)
CA (1) CA2135277C (no)
DE (1) DE69317282D1 (no)
NO (1) NO944247L (no)
NZ (1) NZ252559A (no)
WO (1) WO1993023557A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416728B2 (en) 1992-05-08 2008-08-26 Kyto Biopharma, Inc. Growth blocking agents
US5739287A (en) * 1994-04-08 1998-04-14 University Of Washington Biotinylated cobalamins
US5840880A (en) * 1994-04-08 1998-11-24 Receptagen Corporation Receptor modulating agents
US5869465A (en) * 1994-04-08 1999-02-09 Receptagen Corporation Methods of receptor modulation and uses therefor
DE69528523T2 (de) * 1994-04-08 2003-06-12 Receptagen Corp., Edmonds Rezeptor modulierendes mitteln und entsprechendes verfahren
ATE318844T1 (de) * 1994-09-13 2006-03-15 Kyto Biopharma Inc Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
WO1997014711A1 (en) * 1995-10-19 1997-04-24 Receptagen Corporation Vitamin b12 receptor modulating agents and methods related thereto
US20020102258A1 (en) * 1997-05-12 2002-08-01 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (TR2) antibodies
WO1998051346A1 (en) * 1997-05-12 1998-11-19 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (tr2) antibodies
US6410245B1 (en) * 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
GB9820473D0 (en) * 1998-09-18 1998-11-11 Axis Biochemicals Asa Assay
US6492497B1 (en) * 1999-04-30 2002-12-10 Cambridge Antibody Technology Limited Specific binding members for TGFbeta1
CA2441228A1 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US20040047917A1 (en) * 2002-09-06 2004-03-11 Stephen Wilson Drug delivery and targeting with vitamin B12 conjugates
JP2008513536A (ja) 2004-09-22 2008-05-01 レセプター バイオロジックス インコーポレイテッド プロガストリンに対するモノクローナル抗体
US20080015194A1 (en) * 2006-01-23 2008-01-17 Joseph Errico Methods and compositions of targeted drug development
JP5524610B2 (ja) 2006-04-07 2014-06-18 ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク トランスコバラミン受容体ポリペプチド、核酸およびその調節因子、ならびに細胞の増殖の調節ならびにガンおよびコバラミン欠損症の処置に使用する関連方法
US9044461B2 (en) 2006-04-07 2015-06-02 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
WO2025219395A1 (en) 2024-04-16 2025-10-23 Chu D'angers Treatment of cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
JPS633262A (ja) * 1986-06-24 1988-01-08 Toshiba Corp 網状赤血球の分析方法及び装置

Also Published As

Publication number Publication date
AU4239193A (en) 1993-12-13
DE69317282D1 (de) 1998-04-09
EP0644948B1 (en) 1998-03-04
NO944247D0 (no) 1994-11-07
CA2135277A1 (en) 1993-11-25
AU680822B2 (en) 1997-08-14
NZ252559A (en) 1996-10-28
EP0644948A1 (en) 1995-03-29
US5688504A (en) 1997-11-18
CA2135277C (en) 2001-04-24
JPH07508174A (ja) 1995-09-14
WO1993023557A1 (en) 1993-11-25
ATE163679T1 (de) 1998-03-15
KR950701390A (ko) 1995-03-23

Similar Documents

Publication Publication Date Title
NO944247D0 (no) Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor
FI960567A0 (fi) Monoklonaalinen vasta-aine, joka indusoi apoptoosin
NO961151D0 (no) Antistoffer mot CD40
AU6914798A (en) Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
FI940122A0 (fi) Hakualueita käyttävä solukkojärjestelmä
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
AU7657387A (en) Apoprotein b-100 specific monoclonal antibodies
AU3683395A (en) Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
TR199900943T2 (xx) Pirimidin t�revlerinin haz�rlanma prosesi.
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
WO2002042318A3 (en) Transcobalamin receptor binding conjugates for neutron capture therapy
FR2694628B1 (fr) Cellule photo-electrique, notamment submersible, et attache rapide pour sa fixation sur une source de lumiere ultraviolette.
DK0584368T3 (da) Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof
FR2693561B1 (fr) Source de lumière polarisée et rétroprojecteur utilisant cette source.
KR940000965U (ko) 정량 눈새김 연료운반통
UA8309A (uk) Система виявлення лазерного опромінювання
ES1004160Y (es) Polaina portadora de objetos de uso personal.
DK240388D0 (da) Paahaengsvogn til transport af skiftelad
KR970706308A (ko) 비타민 B_12/트랜스코발아맨 Ⅱ 수용체 및 결합 부위에 대한 항-수용체 및 성장차단제(Anti-receptor and growth blocking agents to the vitamin B_12/transcobalamin Ⅱ receptor and binding sites)
DK87293D0 (da) Soenderdelingsapparat til selektiv soenderdeling af materialer med forskellig brudstyrke
ES1023082Y (es) Hito para la se\alizacion vial.
MX9301870A (es) Antagonistas receptores de angiotensina ii